Mutations in Proline 82 of p53 Impair Its Activation by Pin1 and Chk2 in Response to DNA Damage

REFERENCES

• Baptiste, N., P. Friedlander, X. Chen, and C. Prives. 2002. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Oncogene 21:9–21.
   PubMedGoogle Scholar
• Bartek, J., and J. Lukas. 2003. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3:421–429.
   PubMed Web of Science ®Google Scholar
• Berger, M., R. Vogt Sionov, A. J. Levine, and Y. Haupt. 2001. A role for the polyproline domain of p53 in its regulation by Mdm2. J. Biol. Chem. 276:3785–3790.
   PubMed Web of Science ®Google Scholar
• Chehab, N. H., A. Malikzay, M. Appel, and T. D. Halazonetis. 2000. Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53. Genes Dev. 14:278–288.
   PubMed Web of Science ®Google Scholar
• Chehab, N. H., A. Malikzay, E. S. Stavridi, and T. D. Halazonetis. 1999. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. USA 96:13777–13782.
   PubMed Web of Science ®Google Scholar
• Chipuk, J. E., T. Kuwana, L. Bouchier-Hayes, N. M. Droin, D. D. Newmeyer, M. Schuler, and D. R. Green. 2004. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303:1010–1014.
   PubMed Web of Science ®Google Scholar
• Craig, A., M. Scott, L. Burch, G. Smith, K. Ball, and T. Hupp. 2003. Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain. EMBO Rep. 4:787–792.
   PubMedGoogle Scholar
• Crenshaw, D. G., J. Yang, A. R. Means, and S. Kornbluth. 1998. The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J. 17:1315–1327.
   PubMedGoogle Scholar
• Edwards, S. J., L. Hananeia, M. R. Eccles, Y. F. Zhang, and A. W. Braithwaite. 2003. The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions. Oncogene 22:4517–4523.
   PubMedGoogle Scholar
• Falck, J., C. Lukas, M. Protopopova, J. Lukas, G. Selivanova, and J. Bartek. 2001. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway. Oncogene 20:5503–5510.
   PubMed Web of Science ®Google Scholar
• Haupt, Y., Y. Barak, and M. Oren. 1996. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15:1596–1606.
   PubMed Web of Science ®Google Scholar
• Hayon, I. L., and Y. Haupt. 2002. p53: an internal investigation. Cell Cycle 1:111–116.
   PubMedGoogle Scholar
• Hirao, A., Y. Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S. J. Elledge, and T. W. Mak. 2000. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824–1827.
   PubMed Web of Science ®Google Scholar
• Iwakuma, T., and G. Lozano. 2003. MDM2, an introduction. Mol. Cancer Res. 1:993–1000.
   PubMed Web of Science ®Google Scholar
• Joseph, J. D., E. S. Yeh, K. I. Swenson, A. R. Means, and Winkler. 2003. The peptidyl-prolyl isomerase Pin1. Prog. Cell Cycle Res. 5:477–487.
   PubMedGoogle Scholar
• Lu, K. P. 2003. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 4:175–180.
   PubMedGoogle Scholar
• Ryo, A., M. Nakamura, G. Wulf, Y. C. Liou, and K. P. Lu. 2001. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 3:793–801.
   PubMed Web of Science ®Google Scholar
• Sakamuro, D., P. Sabbatini, E. White, and G. C. Prendergast. 1997. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15:887–898.
   PubMed Web of Science ®Google Scholar
• Shieh, S. Y., J. Ahn, K. Tamai, Y. Taya, and C. Prives. 2000. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:289–300.
   PubMed Web of Science ®Google Scholar
• Sionov, R. V., and Y. Haupt. 1999. The cellular response to p53: the decision between life and death. Oncogene 18:6145–6157.
   PubMed Web of Science ®Google Scholar
• Stukenberg, P. T., and M. W. Kirschner. 2001. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 7:1071–1083.
   PubMedGoogle Scholar
• Sun, X. F., O. Johannsson, S. Hakansson, G. Sellberg, B. Nordenskjold, H. Olsson, and A. Borg. 1996. A novel p53 germline alteration identified in a late onset breast cancer kindred. Oncogene 13:407–411.
   PubMedGoogle Scholar
• Taylor, J. A., Y. Li, M. He, T. Mason, C. Mettlin, W. J. Vogler, S. Maygarden, and E. Liu. 1996. p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res. 56:294–298.
   PubMed Web of Science ®Google Scholar
• Unger, T., T. Juven-Gershon, E. Moallem, M. Berger, R. Vogt Sionov, G. Lozano, M. Oren, and Y. Haupt. 1999. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18:1805–1814.
   PubMed Web of Science ®Google Scholar
• Venot, C., M. Maratrat, C. Dureuil, E. Conseiller, L. Bracco, and L. Debussche. 1998. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 17:4668–4679.
   PubMed Web of Science ®Google Scholar
• Vogt Sionov, R., L. I. Hayon, and Y. Haupt. 2001. The regulation of p53 growth suppression, p. 106–125. In M. V. Blagosklonny (ed.), Cell cycle checkpoints and cancer. Landes Bioscience, Georgetown, Tex.
   Google Scholar
• Walker, K. K., and A. J. Levine. 1996. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA 93:15335–15340.
   PubMed Web of Science ®Google Scholar
• Wulf, G. M., Y. C. Liou, A. Ryo, S. W. Lee, and K. P. Lu. 2002. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 277:47976–47979.
   PubMed Web of Science ®Google Scholar
• Zacchi, P., M. Gostissa, T. Uchida, C. Salvagno, F. Avolio, S. Volinia, Z. Ronai, G. Blandino, C. Schneider, and G. Del Sal. 2002. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 419:853–857.
   PubMed Web of Science ®Google Scholar
• Zheng, H., H. You, X. Z. Zhou, S. A. Murray, T. Uchida, G. Wulf, L. Gu, X. Tang, K. P. Lu, and Z. X. Xiao. 2002. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419:849–853.
   PubMed Web of Science ®Google Scholar
• Zhu, J., J. Jiang, W. Zhou, K. Zhu, and X. Chen. 1999. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity. Oncogene 18:2149–2155.
   PubMedGoogle Scholar